Download the DIA Global Meeting App
The DIA has an app to help navigate meetings from your smart device, and has been updated this year.
The DIA has an app to help navigate meetings from your smart device, and has been updated this year. To get the free app, search "DIA Global" in your device's app store and login to the app with the email you use for DIA Events registration. By selecting "reset password" you can get a new password emailed to you. Once in the app, go to the meeting you want found under the Events icon. The new app features
- Activity Stream that provides real-time updates
- Manage your meeting agenda
- Connect and network with meeting attendees
- Interactive floor plans
- View exhibiting companies with their booth numbers
- Earn points and badges for activity within the app, tallied within the Leaderboard
- Integration with your social media channels
DIA encourages attendees to download the app prior to the meeting so as to enjoy the full benefits of the app and to avoid delays during the download process.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
